The British & Irish Lions have been overwhelmingly backed to continue their good start to their series against Australia this ...

Keyamo has hailed Governor Mbah’s relentless efforts, describing Enugu Air as a triumph of vision and a historic aviation ...

Phase 2 voting is underway for the 2025 MLB All-Star Game presented by Mastercard. Here’s how the races to determine the All-Star starters are shaping up.

In this thrilling #Shorts episode, watch as Elastigirl surprises Mr. Incredible with an unexpected twist! Just when Mr. Incredible thinks he knows what's coming, the situation takes a jaw-dropping ...

In this captivating short video, witness the transformation of Mr. Incredible as he faces bullying. What seems like a dark moment quickly shifts, revealing the true strength and resilience of our ...

Merck KGaA has shed light on the failure in one lupus cohort, while pointing to secondary endpoint wins as proof that enpatoran still deserves a shot.

Following its WWDC keynote on Monday, Apple updated a developer document to indicate that Rosetta 2 will remain available through macOS 27. Rosetta ...

The first patient has been dosed in a phase 2 trial (NCT06971614) investigating MVR-T3011, an oncolytic immunotherapy for patients with BCG-unresponsive high-risk non–muscle invasive bladder cancer ...

MAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical TrialCHICAGO-- (BUSINESS WIRE)-- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the ...

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

A phase 2 study of Vigil Neuroscience’s iluzanebart has missed its biomarker and efficacy endpoints, prompting the Sanofi-bound biotech to stop a long-term extension trial of the TREM2 agonist.

A phase II randomized study of neoadjuvant pembrolizumab (P) alone or in combination with vidutolimod (V) in high-risk resectable melanoma: ECOG-ACRIN EA6194. Comparison of 1 year versus minimum 2 ...